 Cody Cichowitz
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 16 | 2026 | 3195 | 1.510 |
Why?
| | Infectious Disease Transmission, Vertical | 6 | 2021 | 194 | 1.400 |
Why?
| | Pregnancy Complications, Infectious | 6 | 2021 | 440 | 1.250 |
Why?
| | Continuity of Patient Care | 4 | 2019 | 297 | 1.160 |
Why?
| | Cardiovascular Diseases | 4 | 2026 | 2191 | 0.820 |
Why?
| | Tanzania | 11 | 2026 | 72 | 0.720 |
Why?
| | Atherosclerosis | 2 | 2022 | 409 | 0.670 |
Why?
| | Lost to Follow-Up | 2 | 2019 | 20 | 0.630 |
Why?
| | Chest Pain | 1 | 2020 | 99 | 0.620 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 2024 | 237 | 0.580 |
Why?
| | Anemia, Sickle Cell | 3 | 2018 | 318 | 0.560 |
Why?
| | Postpartum Period | 4 | 2019 | 373 | 0.560 |
Why?
| | Air Pollution | 1 | 2022 | 315 | 0.550 |
Why?
| | Contrast Media | 1 | 2021 | 497 | 0.540 |
Why?
| | Parturition | 1 | 2018 | 69 | 0.530 |
Why?
| | Vesicovaginal Fistula | 1 | 2017 | 5 | 0.530 |
Why?
| | Obstetric Labor Complications | 1 | 2017 | 38 | 0.510 |
Why?
| | Anal Canal | 1 | 2018 | 102 | 0.510 |
Why?
| | Ethics, Medical | 1 | 2018 | 91 | 0.510 |
Why?
| | Help-Seeking Behavior | 1 | 2017 | 28 | 0.500 |
Why?
| | Hospitalization | 4 | 2025 | 2460 | 0.500 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 396 | 0.500 |
Why?
| | Neurocognitive Disorders | 1 | 2016 | 33 | 0.490 |
Why?
| | Homosexuality, Male | 1 | 2018 | 231 | 0.470 |
Why?
| | Acute Disease | 1 | 2018 | 1036 | 0.460 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 2 | 2026 | 69 | 0.450 |
Why?
| | Sex Offenses | 1 | 2018 | 196 | 0.440 |
Why?
| | Time-to-Treatment | 1 | 2017 | 251 | 0.440 |
Why?
| | Anti-HIV Agents | 2 | 2025 | 912 | 0.430 |
Why?
| | Blood Pressure | 3 | 2026 | 1782 | 0.430 |
Why?
| | Pneumonia | 1 | 2020 | 636 | 0.420 |
Why?
| | Transgender Persons | 1 | 2018 | 210 | 0.420 |
Why?
| | Sexual Behavior | 1 | 2018 | 495 | 0.400 |
Why?
| | Healthcare Disparities | 1 | 2020 | 736 | 0.400 |
Why?
| | Patient Compliance | 1 | 2017 | 588 | 0.390 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 874 | 0.390 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.380 |
Why?
| | Patient Discharge | 2 | 2019 | 995 | 0.370 |
Why?
| | Echocardiography | 2 | 2026 | 648 | 0.360 |
Why?
| | Anti-Retroviral Agents | 3 | 2019 | 251 | 0.360 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1137 | 0.340 |
Why?
| | Alcoholism | 1 | 2017 | 826 | 0.320 |
Why?
| | Adult | 19 | 2026 | 40872 | 0.300 |
Why?
| | South Africa | 3 | 2019 | 266 | 0.290 |
Why?
| | Health Services Accessibility | 1 | 2017 | 1101 | 0.280 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2026 | 124 | 0.280 |
Why?
| | Depression | 1 | 2017 | 1557 | 0.270 |
Why?
| | Female | 22 | 2026 | 79035 | 0.260 |
Why?
| | Heart Failure | 1 | 2020 | 2326 | 0.250 |
Why?
| | Hypertension | 2 | 2026 | 1276 | 0.250 |
Why?
| | Vulnerable Populations | 2 | 2018 | 176 | 0.240 |
Why?
| | Humans | 28 | 2026 | 145763 | 0.240 |
Why?
| | Masked Hypertension | 1 | 2025 | 2 | 0.230 |
Why?
| | Risk Factors | 9 | 2026 | 10917 | 0.230 |
Why?
| | Pregnancy | 7 | 2021 | 7215 | 0.230 |
Why?
| | Africa | 2 | 2023 | 119 | 0.220 |
Why?
| | Oxazines | 1 | 2025 | 37 | 0.220 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2025 | 44 | 0.220 |
Why?
| | Cohort Studies | 6 | 2025 | 6032 | 0.220 |
Why?
| | Blood Pressure Determination | 1 | 2025 | 145 | 0.210 |
Why?
| | Medication Adherence | 2 | 2019 | 540 | 0.210 |
Why?
| | Myocardial Ischemia | 1 | 2026 | 285 | 0.210 |
Why?
| | HIV Integrase Inhibitors | 1 | 2025 | 79 | 0.200 |
Why?
| | Pyridones | 1 | 2025 | 209 | 0.190 |
Why?
| | Middle Aged | 12 | 2026 | 36302 | 0.190 |
Why?
| | Cross-Sectional Studies | 7 | 2026 | 5922 | 0.190 |
Why?
| | Piperazines | 1 | 2025 | 375 | 0.180 |
Why?
| | Lung Diseases, Obstructive | 1 | 2022 | 43 | 0.170 |
Why?
| | Young Adult | 6 | 2024 | 14251 | 0.170 |
Why?
| | Heart Ventricles | 1 | 2026 | 756 | 0.160 |
Why?
| | Male | 13 | 2026 | 73003 | 0.160 |
Why?
| | Maryland | 1 | 2020 | 67 | 0.160 |
Why?
| | Vascular Stiffness | 1 | 2025 | 487 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2024 | 578 | 0.150 |
Why?
| | World Health Organization | 1 | 2019 | 104 | 0.150 |
Why?
| | Delivery of Health Care | 1 | 2026 | 947 | 0.140 |
Why?
| | Hospital Mortality | 2 | 2025 | 1038 | 0.140 |
Why?
| | Punishment | 1 | 2018 | 20 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 195 | 0.130 |
Why?
| | Acute Pain | 1 | 2018 | 58 | 0.130 |
Why?
| | HIV | 1 | 2018 | 251 | 0.130 |
Why?
| | Aftercare | 1 | 2018 | 222 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8346 | 0.120 |
Why?
| | Prenatal Care | 1 | 2019 | 309 | 0.120 |
Why?
| | Mass Screening | 1 | 2025 | 1361 | 0.120 |
Why?
| | Mortality | 1 | 2019 | 380 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 653 | 0.120 |
Why?
| | Retrospective Studies | 3 | 2020 | 17325 | 0.120 |
Why?
| | Social Stigma | 1 | 2018 | 173 | 0.120 |
Why?
| | Logistic Models | 1 | 2020 | 2139 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 361 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 883 | 0.110 |
Why?
| | Global Health | 1 | 2018 | 403 | 0.110 |
Why?
| | Patient-Specific Modeling | 1 | 2014 | 45 | 0.100 |
Why?
| | Comorbidity | 1 | 2018 | 1662 | 0.100 |
Why?
| | Health Behavior | 1 | 2019 | 791 | 0.100 |
Why?
| | Aged | 5 | 2022 | 26215 | 0.100 |
Why?
| | Poverty | 1 | 2017 | 529 | 0.100 |
Why?
| | Patient Readmission | 1 | 2019 | 772 | 0.100 |
Why?
| | Mothers | 1 | 2018 | 765 | 0.090 |
Why?
| | Pain | 1 | 2018 | 791 | 0.090 |
Why?
| | Pilot Projects | 1 | 2017 | 1897 | 0.090 |
Why?
| | Executive Function | 1 | 2016 | 470 | 0.090 |
Why?
| | Students, Medical | 1 | 2016 | 378 | 0.080 |
Why?
| | Adolescent | 2 | 2022 | 22573 | 0.080 |
Why?
| | Precision Medicine | 1 | 2014 | 461 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5428 | 0.070 |
Why?
| | Lung | 1 | 2022 | 4116 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2383 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2016 | 1149 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2018 | 6464 | 0.060 |
Why?
| | Africa South of the Sahara | 1 | 2026 | 54 | 0.060 |
Why?
| | Counseling | 2 | 2019 | 401 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1101 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2967 | 0.060 |
Why?
| | Ankle Brachial Index | 1 | 2025 | 41 | 0.050 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2025 | 20 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 6085 | 0.050 |
Why?
| | Mercury | 1 | 2024 | 41 | 0.050 |
Why?
| | Cadmium | 1 | 2024 | 68 | 0.050 |
Why?
| | Pulse Wave Analysis | 1 | 2025 | 267 | 0.050 |
Why?
| | Lead | 1 | 2024 | 71 | 0.050 |
Why?
| | Blood Glucose | 1 | 2014 | 2344 | 0.050 |
Why?
| | Cost of Illness | 1 | 2026 | 324 | 0.050 |
Why?
| | Health Policy | 1 | 2026 | 400 | 0.050 |
Why?
| | Environmental Pollutants | 1 | 2024 | 139 | 0.050 |
Why?
| | Ventricular Function, Left | 1 | 2026 | 544 | 0.050 |
Why?
| | Uganda | 1 | 2022 | 90 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2026 | 513 | 0.040 |
Why?
| | Multimorbidity | 1 | 2022 | 65 | 0.040 |
Why?
| | Spirometry | 1 | 2022 | 233 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2022 | 450 | 0.040 |
Why?
| | Carotid Arteries | 1 | 2022 | 208 | 0.040 |
Why?
| | Prospective Studies | 2 | 2026 | 8075 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2123 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 544 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 259 | 0.040 |
Why?
| | Prevalence | 1 | 2025 | 2874 | 0.030 |
Why?
| | Waist Circumference | 1 | 2018 | 143 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2018 | 100 | 0.030 |
Why?
| | Dietary Fats | 1 | 2018 | 308 | 0.030 |
Why?
| | Viral Load | 1 | 2018 | 526 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2019 | 401 | 0.030 |
Why?
| | Health Care Costs | 1 | 2018 | 425 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 553 | 0.030 |
Why?
| | Smoking | 1 | 2022 | 1477 | 0.030 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 51 | 0.030 |
Why?
| | Biological Clocks | 1 | 2014 | 48 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.030 |
Why?
| | Overweight | 1 | 2018 | 614 | 0.020 |
Why?
| | Emotions | 1 | 2016 | 577 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3346 | 0.020 |
Why?
| | Metformin | 1 | 2014 | 329 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1154 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 11793 | 0.010 |
Why?
| | Insulin | 1 | 2014 | 2516 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7133 | 0.010 |
Why?
| | United States | 1 | 2018 | 16123 | 0.010 |
Why?
|
|
Cichowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|